Safety Profile of Dupilumab Approved for Chronic Rhinosinusitis with Nasal Polyposis: Analysis from the European Spontaneous Adverse Event Reporting System Conference

Barbieri, MA, Galletti, C, Sorbara, EE et al. (2022). Safety Profile of Dupilumab Approved for Chronic Rhinosinusitis with Nasal Polyposis: Analysis from the European Spontaneous Adverse Event Reporting System . 45(10), 1156-1157.

cited authors

  • Barbieri, MA; Galletti, C; Sorbara, EE; Cicala, G; Cutroneo, PM; Ciodaro, F; Galletti, B; Spina, E

sustainable development goals

authors

publication date

  • October 1, 2022

keywords

  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • Public, Environmental & Occupational Health
  • Science & Technology
  • Toxicology

publisher

  • ADIS INT LTD

start page

  • 1156

end page

  • 1157

volume

  • 45

issue

  • 10